U.S. Venture Partners related stories
All articles and analysis
Report: Blekko Raises $11.5 MillionBlekko, a stealth search engine operator, has raised $11.5 million in third-round funding, according to TechCrunch http://www.techcrunch.com/2009/07/27/stealth-search-engine-blekko-raises-115-million/ Backers include U.S. Venture Partners and CMEA Capital. The firm previously raised around $6 million. www.blekko.com http://www.blekko.com
- USVP Promotes Ted Maidenberg
U.S. Venture Partners has promoted Ted Maidenberg to the position of principal. Maidenberg joined USVP in 2006, with a focus on business- and consumer-facing software and services. He currently sits on the boards of Media6Degrees and Savings.com.
- Cleantech hasn't deflated, financing has, say VCs
Other funding sources, such as the government, strategic investors, and project finance lenders, will take on larger role
- peHUB Wire: Monday, July 27, 2009
Monday Mouth-Off
- Shaking The MoneyTree: VC Investment (Still) Rises in Q2
Stop me if you've heard this one before: Venture capital investing increased in the second-quarter of 2009, even though investment activity was still much lower than in Q2 2008. Oh yeah, we wrote about it over the weekend /45026/venture-capital-funding-rises-in-q2-healthcare-tops-it/ (and have been What's different this time is that the data comes from MoneyTree, a joint venture of the National Venture Capital Association, PwC and Thomson Reuters. That last one just happens to publish peHUB, which means we trust these numbers a bit more, have access to the actual database and are able to display a gluttonous smorgasborg of charts (see below). The topline number is $3.7 billion invested in 612 U.S.-based companies. This compares to $3.19 billion raised by 601 U.S.-based companies in Q1 2009, and $7.55 billion raised by 1,048 U.S.-based companies in Q2 2008. To use a semi-apt sports analogy, VCs took a baby step off the sidelines, but are nowhere near the line of scrimmage (particularly given that barely over $300 million has been invested thus far in Q3). In terms of industy sectors, IT managed to (barely) keep its unbeaten streak alive against life sciences ($1.72b vs. $1.53b). This is different than what the earlier data from Dow Jones showed, and MoneyTree does show biotech as its fattest cash cow in a more segmented analysis.
- Week in deals, July 13, 2009
Summary of tech companies and other businesses that raised financing in the past week
- Intellikine Raises $51 Million
Intellikine Inc., a La Jolla, Calif.-based developer of small molecule drugs for cancer, inflammation and autoimmune diseases, has raised $51 million in Series B funding. Novartis Bioventures led the round, and was joined by U.S. Venture Partners, Biogen Idec and FinTech Global Capital. Return backers included Abingworth, CMEA Capital and Sofinnova Ventures. The round includes a $28.5 million initial calldown, with the remainder dependent on the achievement of certain milestones. Intellikine previously raised $12.5 million.
- peHUB Wire: Thursday, July 9, 2009
Random Ramblings
- peHUB Wire: Thursday, July 9, 2009
Random Ramblings
- Westly: We'll have a dozen cleantech IPOs
Cleantech investor predicts many cleantech companies are ripe for an IPO